Mast cells and basophils in cutaneous immune responses

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 2, 2015, Pages 131-140

  Otsuka, A ^a   Kabashima, K ^a,b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

allergic contact dermatitis; atopic dermatitis; basophil; mast cell

Indexed keywords

ALLERGIC REACTION; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; BASOPHIL; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CHRONIC IDIOPATHIC URTICARIA; CONTACT ALLERGY; CUTANEOUS BASOPHIL HYPERSENSITIVITY; DELAYED HYPERSENSITIVITY; HUMAN; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; JONES MOTE HYPERSENSITIVITY; LYMPHOCYTIC INFILTRATION; MAST CELL; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN ALLERGY; SKIN DISEASE; SKIN FUNCTION; SKIN SENSITIZATION; TH2 CELL; ANIMAL; DERMATITIS, ATOPIC; DISEASE MODEL; HYPERSENSITIVITY; IMMUNITY; IMMUNOLOGY; LEUKAPHERESIS; METABOLISM; SKIN; SKIN DISEASES;

ANIMALS; BASOPHILS; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; HUMANS; HYPERSENSITIVITY; IMMUNITY; LEUKOCYTE REDUCTION PROCEDURES; MAST CELLS; SKIN; SKIN DISEASES;

EID: 84920759141     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12526     Document Type: Review

References (106)

1. Migalovich-Sheikhet H, Friedman S, Mankuta D, Levi-Schaffer F,. Novel identified receptors on mast cells. Front Immunol 2012; 3: 238.
2. Schneider E, Thieblemont N, De Moraes ML, Dy M,. Basophils: new players in the cytokine network. Eur Cytokine Netw 2010; 21: 142-153.
3. Gilfillan AM, Beaven MA,. Regulation of mast cell responses in health and disease. Crit Rev Immunol 2011; 31: 475-529.
4. Karasuyama H, Mukai K, Obata K, Tsujimura Y, Wada T,. Nonredundant roles of basophils in immunity. Annu Rev Immunol 2011; 29: 45-69.
5. Lichtenstein LM, Bochner BS,. The role of basophils in asthma. Ann N Y Acad Sci 1991; 629: 48-61.
6. Otsuka A, Kubo M, Honda T, Egawa G, Nakajima S, Tanizaki H, et al. Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity. PLoS ONE 2011; 6: e25538.
7. Otsuka A, Nakajima S, Kubo M, Egawa G, Honda T, Kitoh A, et al. Basophils are required for the induction of Th2 immunity to haptens and peptide antigens. Nat Commun 2013; 4: 1739.
8. Galli SJ, Borregaard N, Wynn TA,. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 2011; 12: 1035-1044.
9. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M,. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005; 23: 749-786.
10. Russell ES,. Hereditary anemias of the mouse: a review for geneticists. Adv Genet 1979; 20: 357-459.
11. Waskow C, Terszowski G, Costa C, Gassmann M, Rodewald HR,. Rescue of lethal c-KitW/W mice by erythropoietin. Blood 2004; 104: 1688-1695.
12. Puddington L, Olson S, Lefrancois L,. Interactions between stem cell factor and c-Kit are required for intestinal immune system homeostasis. Immunity 1994; 1: 733-739.
13. Zhou JS, Xing W, Friend DS, Austen KF, Katz HR,. Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis. J Exp Med 2007; 204: 2797-2802.
14. Feyerabend TB, Terszowski G, Tietz A, Blum C, Luche H, Gossler A, et al. Deletion of Notch1 converts pro-T cells to dendritic cells and promotes thymic B cells by cell-extrinsic and cell-intrinsic mechanisms. Immunity 2009; 30: 67-79.
15. Musch W, Wege AK, Mannel DN, Hehlgans T,. Generation and characterization of alpha-chymase-Cre transgenic mice. Genesis 2008; 46: 163-166.
16. Scholten J, Hartmann K, Gerbaulet A, Krieg T, Muller W, Testa G, et al. Mast cell-specific Cre/loxP-mediated recombination in vivo. Transgenic Res 2008; 17: 307-315.
17. Dudeck A, Dudeck J, Scholten J, Petzold A, Surianarayanan S, Kohler A, et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 2011; 34: 973-984.
18. Feyerabend TB, Weiser A, Tietz A, Stassen M, Harris N, Kopf M, et al. Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. Immunity 2011; 35: 832-844.
19. Lilla JN, Chen CC, Mukai K, BenBarak MJ, Franco CB, Kalesnikoff J, et al. Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1 fl/fl mice. Blood 2011; 118: 6930-6938.
20. Voehringer D, Liang HE, Locksley RM,. Homeostasis and effector function of lymphopenia-induced "memory-like" T cells in constitutively T cell-depleted mice. J Immunol 2008; 180: 4742-4753.
21. Ohnmacht C, Schwartz C, Panzer M, Schiedewitz I, Naumann R, Voehringer D,. Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths. Immunity 2010; 33: 364-374.
22. Kojima T, Obata K, Mukai K, Sato S, Takai T, Minegishi Y, et al. Mast cells and basophils are selectively activated in vitro and in vivo through CD200R3 in an IgE-independent manner. J Immunol 2007; 179: 7093-7100.
23. Obata K, Mukai K, Tsujimura Y, Ishiwata K, Kawano Y, Minegishi Y, et al. Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood 2007; 110: 913-920.
24. Hammad H, Plantinga M, Deswarte K, Pouliot P, Willart MA, Kool M, et al. Inflammatory dendritic cells-not basophils-are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med 2010; 207: 2097-2111.
25. Poorafshar M, Helmby H, Troye-Blomberg M, Hellman L,. MMCP-8, the first lineage-specific differentiation marker for mouse basophils. Elevated numbers of potent IL-4-producing and MMCP-8-positive cells in spleens of malaria-infected mice. Eur J Immunol 2000; 30: 2660-2668.
26. Sullivan BM, Liang HE, Bando JK, Wu D, Cheng LE, McKerrow JK, et al. Genetic analysis of basophil function in vivo. Nat Immunol 2011; 12: 527-535.
27. Wada T, Ishiwata K, Koseki H, Ishikura T, Ugajin T, Ohnuma N, et al. Selective ablation of basophils in mice reveals their nonredundant role in acquired immunity against ticks. J Clin Invest 2010; 120: 2867-2875.
28. Mukai K, BenBarak MJ, Tachibana M, Nishida K, Karasuyama H, Taniuchi I, et al. Critical role of P1-Runx1 in mouse basophil development. Blood 2012; 120: 76-85.
29. Sawaguchi M, Tanaka S, Nakatani Y, Harada Y, Mukai K, Matsunaga Y, et al. Role of mast cells and basophils in IgE responses and in allergic airway hyperresponsiveness. J Immunol 2012; 188: 1809-1818.
30. Sayed BA, Christy A, Quirion MR, Brown MA,. The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol 2008; 26: 705-739.
31. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB,. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002; 297: 1689-1692.
32. Kneilling M, Hultner L, Pichler BJ, Mailhammer R, Morawietz L, Solomon S, et al. Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice. Arthritis Rheum 2007; 56: 1806-1816.
33. Orinska Z, Maurer M, Mirghomizadeh F, Bulanova E, Metz M, Nashkevich N, et al. IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat Med 2007; 13: 927-934.
34. Maurer M, Wedemeyer J, Metz M, Piliponsky AM, Weller K, Chatterjea D, et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 2004; 432: 512-516.
35. Charlesworth EN,. The role of basophils and mast cells in acute and late reactions in the skin. Allergy 1997; 52 (34 Suppl): 31-43.
36. Jiang WY, Chattedee AD, Raychaudhuri SP, Raychaudhuri SK, Farber EM,. Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. Int J Dermatol 2001; 40: 699-703.
37. Crisp AJ,. Mast cells in rheumatoid arthritis. J R Soc Med 1984; 77: 450-451.
38. Ito Y, Satoh T, Takayama K, Miyagishi C, Walls AF, Yokozeki H,. Basophil recruitment and activation in inflammatory skin diseases. Allergy 2011; 66: 1107-1113.
39. Otsuka A, Ozaki M, Horiguchi Y, Murata Y, Kumano K, Nogami R, et al. Basophils infiltrate the skin lesions in lepromatous leprosy. Acta Derm Venereol 2013; 93: 88-89.
40. Otsuka A, Miyagawa-Hayashino A, Walls AF, Miyachi Y, Kabashima K,. Comparison of basophil infiltration into the skin between eosinophilic pustular folliculitis and neutrophilic folliculitis. J Eur Acad Dermatol Venereol 2012; 26: 527-529.
41. Nakahigashi K, Otsuka A, Tomari K, Miyachi Y, Kabashima K,. Evaluation of basophil infiltration into the skin lesions of tick bites. Case Rep Dermatol 2013; 5: 48-51.
42. Kabashima K,. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci 2013; 70: 3-11.
43. Otsuka A, Doi H, Egawa G, Maekawa A, Fujita T, Nakamizo S, et al. Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression. J Allergy Clin Immunol 2013; 133: 139-146.
44. Moniaga CS, Egawa G, Kawasaki H, Hara-Chikuma M, Honda T, Tanizaki H, et al. Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract. Am J Pathol 2010; 176: 2385-2393.
45. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004; 5: 752-760.
46. Raap U, Wichmann K, Bruder M, Stander S, Wedi B, Kapp A, et al. Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol 2008; 122: 421-423.
47. Otsuka A, Tanioka M, Nakagawa Y, Honda T, Ikoma A, Miyachi Y, et al. Effects of cyclosporine on pruritus and serum IL-31 levels in patients with atopic dermatitis. Eur J Dermatol 2011; 21: 816-817.
48. Otsuka A, Honda T, Doi H, Miyachi Y, Kabashima K,. An H1-histamine receptor antagonist decreases serum interleukin-31 levels in patients with atopic dermatitis. Br J Dermatol 2011; 164: 455-456.
49. Niyonsaba F, Ushio H, Hara M, Yokoi H, Tominaga M, Takamori K, et al. Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells. J Immunol 2010; 184: 3526-3534.
50. Kopfnagel V, Harder J, Werfel T,. Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions. Curr Opin Allergy Clin Immunol 2013; 13: 531-536.
51. Alenius H, Laouini D, Woodward A, Mizoguchi E, Bhan AK, Castigli E, et al. Mast cells regulate IFN-gamma expression in the skin and circulating IgE levels in allergen-induced skin inflammation. J Allergy Clin Immunol 2002; 109: 106-113.
52. Oiwa M, Satoh T, Watanabe M, Niwa H, Hirai H, Nakamura M, et al. CRTH2-dependent, STAT6-independent induction of cedar pollen dermatitis. Clin Exp Allergy 2008; 38: 1357-1366.
53. Abboud G, Staumont-Salle D, Kanda A, Roumier T, Deruytter N, Lavogiez C, et al. Fc(epsilon)RI and FcgammaRIII/CD16 differentially regulate atopic dermatitis in mice. J Immunol 2009; 182: 6517-6526.
54. Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM,. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988; 81: 580-589.
55. Perrigoue JG, Saenz SA, Siracusa MC, Allenspach EJ, Taylor BC, Giacomin PR, et al. MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat Immunol 2009; 10: 697-705.
56. Sokol CL, Chu NQ, Yu S, Nish SA, Laufer TM, Medzhitov R,. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol 2009; 10: 713-720.
57. Yoshimoto T, Yasuda K, Tanaka H, Nakahira M, Imai Y, Fujimori Y, et al. Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nat Immunol 2009; 10: 706-712.
58. Phythian-Adams AT, Cook PC, Lundie RJ, Jones LH, Smith KA, Barr TA, et al. CD11c depletion severely disrupts Th2 induction and development in vivo. J Exp Med 2010; 207: 2089-2096.
59. Nakajima S, Igyarto BZ, Honda T, Egawa G, Otsuka A, Hara-Chikuma M, et al. Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. J Allergy Clin Immunol 2012; 129: 1048-1055.
60. Poulsen BC, Poulsen LK, Jensen BM,. Detection of MHC class II expression on human basophils is dependent on antibody specificity but independent of atopic disposition. J Immunol Methods 2012; 381: 66-69.
61. Voskamp AL, Prickett SR, Mackay F, Rolland JM, O'Hehir RE,. MHC class II expression in human basophils: induction and lack of functional significance. PLoS ONE 2013; 8: e81777.
62. Honda T, Egawa G, Grabbe S, Kabashima K,. Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis. J Invest Dermatol 2013; 133: 303-315.
63. Honda T, Otsuka A, Tanizaki H, Minegaki Y, Nagao K, Waldmann H, et al. Enhanced murine contact hypersensitivity by depletion of endogenous regulatory T cells in the sensitization phase. J Dermatol Sci 2011; 61: 144-147.
64. Grabbe S, Schwarz T,. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 1998; 19: 37-44.
65. Romani N, Clausen BE, Stoitzner P,. Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev 2010; 234: 120-141.
66. Honda T, Nakajima S, Egawa G, Ogasawara K, Malissen B, Miyachi Y, et al. Compensatory role of Langerhans cells and langerin-positive dermal dendritic cells in the sensitization phase of murine contact hypersensitivity. J Allergy Clin Immunol 2010; 125: 1154-1156.
67. Kitawaki T, Kadowaki N, Sugimoto N, Kambe N, Hori T, Miyachi Y, et al. IgE-activated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells. Int Immunol 2006; 18: 1789-1799.
68. Jawdat DM, Albert EJ, Rowden G, Haidl ID, Marshall JS,. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J Immunol 2004; 173: 5275-5282.
69. Suto H, Nakae S, Kakurai M, Sedgwick JD, Tsai M, Galli SJ,. Mast cell-associated TNF promotes dendritic cell migration. J Immunol 2006; 176: 4102-4112.
70. Dudeck A, Suender CA, Kostka SL, von Stebut E, Maurer M,. Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function. Eur J Immunol 2011; 41: 1883-1893.
71. Dawicki W, Jawdat DW, Xu N, Marshall JS,. Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node. J Immunol 2010; 184: 2116-2123.
72. Kabashima K, Narumiya S,. The DP receptor, allergic inflammation and asthma. Prostaglandins Leukot Essent Fatty Acids 2003; 69: 187-194.
73. Hammad H, de Heer HJ, Soullie T, Hoogsteden HC, Trottein F, Lambrecht BN,. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. J Immunol 2003; 171: 3936-3940.
74. Askenase PW, Van Loveren H, Kraeuter-Kops S, Ron Y, Meade R, Theoharides TC, et al. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J Immunol 1983; 131: 2687-2694.
75. Biedermann T, Kneilling M, Mailhammer R, Maier K, Sander CA, Kollias G, et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 2000; 192: 1441-1452.
76. Galli SJ, Hammel I,. Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science 1984; 226: 710-713.
77. Mekori YA, Galli SJ,. Undiminished immunologic tolerance to contact sensitivity in mast cell-deficient W/Wv and Sl/Sld mice. J Immunol 1985; 135: 879-885.
78. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ,. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007; 8: 1095-1104.
79. Swope VB, Sauder DN, McKenzie RC, Sramkoski RM, Krug KA, Babcock GF, et al. Synthesis of interleukin-1 alpha and beta by normal human melanocytes. J Invest Dermatol 1994; 102: 749-753.
80. Yu N, Zhang S, Zuo F, Kang K, Guan M, Xiang L,. Cultured human melanocytes express functional toll-like receptors 2-4, 7 and 9. J Dermatol Sci 2009; 56: 113-120.
81. Piliponsky AM, Chen CC, Grimbaldeston MA, Burns-Guydish SM, Hardy J, Kalesnikoff J, et al. Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice. Am J Pathol 2010; 176: 926-938.
82. Katz SI,. Recruitment of basophils in delayed hypersensitivity reactions. J Invest Dermatol 1978; 71: 70-75.
83. Richerson HB, Dvorak HF, Leskowitz S,. Cutaneous basophil hypersensitivity. I. A new look at the Jones-Mote reaction, general characteristics. J Exp Med 1970; 132: 546-557.
84. Otsuka A, Matsunaga I, Komori T, Tomita K, Toda Y, Manabe T, et al. Trehalose dimycolate elicits eosinophilic skin hypersensitivity in mycobacteria-infected guinea pigs. J Immunol 2008; 181: 8528-8533.
85. Mukai K, Matsuoka K, Taya C, Suzuki H, Yokozeki H, Nishioka K, et al. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 2005; 23: 191-202.
86. Egawa M, Mukai K, Yoshikawa S, Iki M, Mukaida N, Kawano Y, et al. Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. Immunity 2013; 38: 570-580.
87. Tsujimura Y, Obata K, Mukai K, Shindou H, Yoshida M, Nishikado H, et al. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity 2008; 28: 581-589.
88. Siracusa MC, Kim BS, Spergel JM, Artis D,. Basophils and allergic inflammation. J Allergy Clin Immunol 2013; 132: 789-801.
89. Eckman JA, Hamilton RG, Gober LM, Sterba PM, Saini SS,. Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies. J Invest Dermatol 2008; 128: 1956-1963.
90. Yasnowsky KM, Dreskin SC, Efaw B, Schoen D, Vedanthan PK, Alam R, et al. Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol 2006; 117: 1430-1434.
91. Ying S, Kikuchi Y, Meng Q, Kay AB, Kaplan AP,. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 2002; 109: 694-700.
92. Hennino A, Berard F, Guillot I, Saad N, Rozieres A, Nicolas JF,. Pathophysiology of urticaria. Clin Rev Allergy Immunol 2006; 30: 3-11.
93. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001; 25: 603-625.
94. Harvima IT, Nilsson G, Suttle MM, Naukkarinen A,. Is there a role for mast cells in psoriasis? Arch Dermatol Res 2008; 300: 461-478.
95. Rothe MJ, Nowak M, Kerdel FA,. The mast cell in health and disease. J Am Acad Dermatol 1990; 23: 615-624.
96. Badertscher K, Bronnimann M, Karlen S, Braathen LR, Yawalkar N,. Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis. Arch Dermatol Res 2005; 296: 503-506.
97. Wintroub BU, Mihm MC Jr, Goetzl EJ, Soter NA, Austen KF,. Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. N Engl J Med 1978; 298: 417-421.
98. Gan PY, Summers SA, Ooi JD, O'Sullivan KM, Tan DS, Muljadi RC, et al. Mast cells contribute to peripheral tolerance and attenuate autoimmune vasculitis. J Am Soc Nephrol 2012; 23: 1955-1966.
99. Ravinal RC, Costa RS, Coimbra TM, Dantas M, dos Reis MA,. Mast cells, TGF-beta1 and myofibroblasts expression in lupus nephritis outcome. Lupus 2005; 14: 814-821.
100. Yukawa S, Yamaoka K, Sawamukai N, Shimajiri S, Kubo S, Miyagawa I, et al. Dermal mast cell density in fingers reflects severity of skin sclerosis in systemic sclerosis. Mod Rheumatol 2013; 23: 1151-1157.
101. Kolb HJ,. Mast cells and GVHD: old cells with a new role. Blood 2013; 122: 3556-3557.
102. Aroni K, Tsagroni E, Kavantzas N, Patsouris E, Ioannidis E,. A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process. Arch Dermatol Res 2008; 300: 125-131.
103. Malaviya R, Ikeda T, Ross E, Abraham SN,. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996; 381: 77-80.
104. Urb M, Sheppard DC,. The role of mast cells in the defence against pathogens. PLoS Pathog 2012; 8: e1002619.
105. Ch'ng S, Wallis RA, Yuan L, Davis PF, Tan ST,. Mast cells and cutaneous malignancies. Mod Pathol 2006; 19: 149-159.
106. Morshed M, Hlushchuk R, Simon D, Walls AF, Obata-Ninomiya K, Karasuyama H, et al. NADPH oxidase-independent formation of extracellular DNA traps by basophils. J Immunol 2014; 192: 5314-5323.